The University of Chicago Header Logo

Connection

David Rubin to Interleukin-23 Subunit p19

This is a "connection" page, showing publications David Rubin has written about Interleukin-23 Subunit p19.
Connection Strength

0.059
  1. Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trial. Lancet Gastroenterol Hepatol. 2026 04; 11(4):284-298.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.